NanoViricides
NNVC
#10380
Rank
$38.75 M
Marketcap
$1.52
Share price
-1.94%
Change (1 day)
-3.80%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): -$0.44

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -$0.44. In 2025 the company made an earnings per share (EPS) of -$0.63 an increase over its 2024 EPS that were of -$0.70.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$0.44-30.16%
2025-$0.63-10%
2024-$0.70-5.41%
2023-$0.745.71%
2022-$0.70-13.58%
2021-$0.81-66.11%
2020-$2.391.7%
2019-$2.35-10.98%
2018-$2.64-22.35%
2017-$3.40-10.53%
2016-$3.80375%
2015-$0.80-85.19%
2014-$5.4042.11%
2013-$3.8026.67%
2012-$3.00-6.25%
2011-$3.2014.28%
2010-$2.80100%
2009-$1.40-0%
2008-$1.40-33.33%
2007-$2.10-0%
2006-$2.104445.07%
2005-$0.04620

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
$7.42-1,786.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$3.57-912.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$3.56-909.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$3.89-983.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-$0.54 22.73%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-$1.73 293.18%๐Ÿ‡บ๐Ÿ‡ธ USA